
is tasked to provide evidence-based input on health technology and clinical practice.
Latest fromMaHTAS

AskCPG is your new AI-powered clinical assistant!
Good news, everyone!
Tired of digging through 200-page CPG PDFs during rounds? Stop scrolling and start healing.
AskCPG is your new AI-powered clinical assistant, designed to give you precise, evidence-based answers for your clinical practice in seconds, thus no manual searching required.
Rest assured, every piece of info is rooted from our evidence-based Clinical Practice Guidelines developed by MaHTAS. Trusted science, proven results.
How to get started:
1. Access the platform: Access it via the MaHTAS official portal.
2. Ask your question: Type your clinical query in plain language (e.g., "What is the management protocol for dengue with warning signs?").
3. Get cited answers: Receive a concise, structured response with direct links back to the official CPG source.
This platform is built for the Malaysian Frontliner.
A huge shoutout to the team at QMed for developing this intuitive system. By collaborating with MaHTAS, they’ve made clinical guidelines faster, smarter, and easier to use at the point of care.
Health Technology Assessment (HTA) and Clinical Practice Guidelines (CPG) Council Meeting No. 2/2026
Date: 12 November 2026
MaHTAS successfully convened the Health Technology Assessment (HTA) and Clinical Practice Guidelines (CPG) Council Meeting No. 2/2026 on 12 November 2026, chaired by the Director-General of Health Malaysia and attended by 29 key stakeholders. The meeting endorsed five CPGs, two HTA reports and eight Technology Reviews, alongside presentations of three TechBrief Horizon Scanning reports and the Guidance on Patient and Public Involvement (PPI) in HTA. The meeting marked another significant milestone in MaHTAS’s efforts to strengthen evidence-informed healthcare policies and decision-making in Malaysia. MaHTAS extends its appreciation to all Council members, experts, collaborators and the team for their continued contributions and commitment.
ISPOR Europe 2026
Date: 9-11 November 2026
Dr. Roza Sarimin, Head of the Health Technology Assessment Unit, represented MaHTAS at ISPOR Europe 2026, held from 9–11 November under the theme “Shaping the Future of Access through Science and Policy”. The forum explored the role of Health Technology Assessment (HTA), Health Economics and Outcomes Research (HEOR), and responsible AI integration in advancing patient-centred care. Key discussions highlighted the importance of AI governance, human oversight and the expanding role of HTA in shaping healthcare policies, guiding investments and balancing innovation with affordability and healthcare sustainability. The event also provided valuable opportunities for global and regional knowledge-sharing, collaboration and strengthening evidence-informed healthcare decision-making.
HTAi Asia Policy Forum 2026 | Tokyo, Japan
Date: 4-6 November 2026
MaHTAS was represented by Dr. Syaqirah Akmal and Dr. Tengku Noor Farhana Tengku Khalid at the HTAi Asia Policy Forum 2026, held from 4–6 November in Tokyo, Japan, themed “The Promise and Perils of AI”. The forum provided an international platform to discuss the evolving role of artificial intelligence in healthcare and Health Technology Assessment (HTA). The representatives also visited Intuitive Surgical to gain insights into robotic-assisted surgical technology and its applications in modern healthcare. The visit further highlighted the importance of evidence-based assessment in guiding the adoption and implementation of advanced medical technologies, including robotic-assisted surgery in Malaysia.
MaHTAS is responsible in assessing health technologies and advocating evidence-informed decision-making for better health care.






